Literature DB >> 27519258

Male partner circumcision associated with lower Trichomonas vaginalis incidence among pregnant and postpartum Kenyan women: a prospective cohort study.

Jillian Pintye1,2, Alison L Drake1, Jennifer A Unger1,3, Daniel Matemo4, John Kinuthia4, R Scott McClelland1,5,6,7, Grace John-Stewart1,5,6,8.   

Abstract

OBJECTIVE: Trichomonas vaginalis is the world's most common curable STI and has implications for reproductive health in women. We determined incidence and correlates of T. vaginalis in an HIV-uninfected peripartum cohort.
METHODS: Women participating in a prospective study of peripartum HIV acquisition in Western Kenya were enrolled during pregnancy and followed until 9 months post partum. T. vaginalis was assessed every 1-3 months using wet mount microscopy. Correlates of incident T. vaginalis were determined using Cox proportional hazards models.
RESULTS: Among 1271 women enrolled, median age was 22 years (IQR 19-27) and gestational age was 22 weeks (IQR 18-26); most (78%) were married and had uncircumcised male partners (69%). Prevalent T. vaginalis was detected in 81 women (6%) at enrolment. Among women without T. vaginalis at enrolment, 112 had T. vaginalis detected during 1079 person-years of follow-up (10.4 per 100 person-years). After adjustment for socio-economic factors, male partner circumcision status, pregnancy status and other STIs, T. vaginalis incidence was higher during pregnancy than post partum (22.3 vs 7.7 per 100 person-years, adjusted HR (aHR) 3.68, 95% CI 1.90 to 7.15, p<0.001). Women with circumcised male partners had a 58% lower risk of incident T. vaginalis compared with women with uncircumcised partners (aHR 0.42, 95% CI 0.23 to 0.76, p=0.004). Employed women had lower risk of incident T. vaginalis than unemployed women (aHR 0.49, 95% CI 0.31 to 0.79, p=0.003); recent STI was associated with increased T. vaginalis risk (aHR 2.97, 95% CI 1.49 to 5.94, p=0.002).
CONCLUSIONS: T. vaginalis was relatively common in this peripartum cohort. Male circumcision may confer benefits in preventing T. vaginalis. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  EPIDEMIOLOGY (CLINICAL); PREGNANCY; TRICHOMONAS; WOMEN

Mesh:

Year:  2016        PMID: 27519258      PMCID: PMC5518938          DOI: 10.1136/sextrans-2016-052629

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  28 in total

1.  Treatment of trichomoniasis in pregnancy in sub-Saharan Africa does not appear to be associated with low birth weight or preterm birth.

Authors:  Elizabeth Stringer; Jennifer S Read; Irving Hoffman; Megan Valentine; Said Aboud; Robert L Goldenberg
Journal:  S Afr Med J       Date:  2010-01

2.  Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus.

Authors:  Prashini Moodley; David Wilkinson; Cathy Connolly; Jack Moodley; A Willem Sturm
Journal:  Clin Infect Dis       Date:  2002-01-07       Impact factor: 9.079

Review 3.  Global epidemiology of Trichomonas vaginalis.

Authors:  Danielle N Poole; R Scott McClelland
Journal:  Sex Transm Infect       Date:  2013-06-06       Impact factor: 3.519

4.  Validity of the vaginal discharge algorithm among pregnant and non-pregnant women in Nairobi, Kenya.

Authors:  K Fonck; N Kidula; W Jaoko; B Estambale; P Claeys; J Ndinya-Achola; P Kirui; J Bwayo; M Temmerman
Journal:  Sex Transm Infect       Date:  2000-02       Impact factor: 3.519

5.  Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition.

Authors:  R Scott McClelland; Laura Sangare; Wisal M Hassan; Ludo Lavreys; Kishorchandra Mandaliya; James Kiarie; Jeckoniah Ndinya-Achola; Walter Jaoko; Jared M Baeten
Journal:  J Infect Dis       Date:  2007-01-22       Impact factor: 5.226

6.  High prevalence and incidence of asymptomatic sexually transmitted infections during pregnancy and postdelivery in KwaZulu Natal, South Africa.

Authors:  Dhayendre Moodley; Prashini Moodley; Motshedisi Sebitloane; Deepak Soowamber; Heather Luz McNaughton-Reyes; Allison K Groves; Suzanne Maman
Journal:  Sex Transm Dis       Date:  2015-01       Impact factor: 2.830

7.  The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004.

Authors:  Madeline Sutton; Maya Sternberg; Emilia H Koumans; Geraldine McQuillan; Stuart Berman; Lauri Markowitz
Journal:  Clin Infect Dis       Date:  2007-10-15       Impact factor: 9.079

8.  The effects of male circumcision on female partners' genital tract symptoms and vaginal infections in a randomized trial in Rakai, Uganda.

Authors:  Ronald H Gray; Godfrey Kigozi; David Serwadda; Frederick Makumbi; Fred Nalugoda; Stephen Watya; Laurence Moulton; Michael Z Chen; Nelson K Sewankambo; Noah Kiwanuka; Victor Sempijja; Tom Lutalo; Joseph Kagayii; Fred Wabwire-Mangen; Renée Ridzon; Melanie Bacon; Maria J Wawer
Journal:  Am J Obstet Gynecol       Date:  2008-10-30       Impact factor: 8.661

Review 9.  Trichomonas vaginalis as a cause of perinatal morbidity: a systematic review and meta-analysis.

Authors:  Bronwyn J Silver; Rebecca J Guy; John M Kaldor; Muhammad S Jamil; Alice R Rumbold
Journal:  Sex Transm Dis       Date:  2014-06       Impact factor: 2.830

10.  Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy.

Authors:  H Minkoff; A N Grunebaum; R H Schwarz; J Feldman; M Cummings; W Crombleholme; L Clark; G Pringle; W M McCormack
Journal:  Am J Obstet Gynecol       Date:  1984-12-15       Impact factor: 8.661

View more
  4 in total

1.  A comparison of the prevalence of sexually transmitted infections among circumcised and uncircumcised adult males in Rustenburg, South Africa: a cross-sectional study.

Authors:  Blanchard Mbay Iyemosolo; Tawanda Chivese; Tonya M Esterhuizen
Journal:  BMC Public Health       Date:  2021-04-06       Impact factor: 3.295

2.  Sexual function after voluntary medical male circumcision for human immunodeficiency virus prevention: Results from a programmatic delivery setting in Botswana.

Authors:  Jillian C Pintye; Kathleen E Wirth; Conrad Ntsuape; Nora J Kleinman; Lisa Spees; Bazghina-Werq Semo; Shreshth Mawandia; Jenny Ledikwe
Journal:  South Afr J HIV Med       Date:  2020-04-20       Impact factor: 2.744

3.  Critical evaluation of arguments opposing male circumcision: A systematic review.

Authors:  Brian J Morris; Stephen Moreton; John N Krieger
Journal:  J Evid Based Med       Date:  2019-09-08

Review 4.  Genitourinary Infections Related to Circumcision and the Potential Impact on Male Infertility.

Authors:  Nahid Punjani; Spyridon P Basourakos; Quincy G Nang; Richard K Lee; Marc Goldstein; Joseph P Alukal; Philip S Li
Journal:  World J Mens Health       Date:  2021-05-18       Impact factor: 5.400

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.